瘤胃内丁酸钠灌注对山羊瘤胃发酵类型的影响

本试验通过对青年山羊进行瘤胃丁酸钠灌注研究其对瘤胃发酵类型的影响。6只安装有瘤胃瘘管的山羊分为试验组(n=3)和对照组(n=3),每天饲喂精料2次,并自由采食羊草。试验组每日早晨喂食1 h后开始每天按体重灌注丁酸钠(0.3 g/kg),对照组灌注等量蒸馏水,持续14 d。于灌注期的第1,5,10和14天分别于灌注前1.5 h,灌注后2 h、4 h采集瘤胃液,以气相色谱测定挥发性脂肪酸(VFA)的浓度。结果显示:灌注前、后,试验组瘤胃内乙酸、丙酸摩尔百分比和总挥发性脂肪酸浓度无显著变化;两组之间差异不显著。但试验组丁酸摩尔百分比在灌注2 h后显著上升(P<0.01),4 h后呈下降趋势,次日采食前恢复至正常生理范围。对照组与试验组pH在各采样时间点间基本无显著差异。试验表明青年山羊瘤胃灌注该剂量丁酸钠不引起瘤胃发酵类型的改变。     

Effect of trauma on plasma glucagon and insulin concentrations in sheep.

Portal plasma glucagon and insulin concentrations were measured before and after acute trauma (liver biosy). The trauma was sufficient to increase glucagon concentrations and depress insulin concentrations. These changes were associated with a marked hyperglycemia. Infusion of glucagon was insufficient to prevent stress inhibition of insulin secretion. The stimulation of glucagon secretion and inhibition of insulin secretion were of about one hour duration. These findings indicate that glucagon and insulin in conjunction with the nervous system may play an important role in the development of stress related hyperglycemia.     

Effects of ruminal infusion of volatile fatty acids on plasma concentration of growth hormone and insulin in sheep.

In an initial experiment we observed postprandial changes in plasma concentrations of growth hormone (GH), insulin, glucagon, and somatostatin (SRIF) in sheep. We then examined whether increasing the rumen concentration of volatile fatty acids (VFA) by infusing a VFA mixture at three rates (53.5, 107, and 214 micromol/kg/min for 4 hr) mimicked the postprandial changes in hormone secretion. Feeding significantly (P < 0.05) suppressed the plasma GH concentration for 6 hr, whereas it significantly (P < 0.05) increased plasma concentrations of insulin, glucagon, and SRIF. Plasma glucose levels tended to decrease after feeding but then gradually increased over the prefeeding level (P < 0.05). Intraruminal infusion of the VFA mixture at 107 micromol/kg/min caused similar changes in ruminal VFA concentrations to those seen after feeding. The infusion significantly (P < 0.05) suppressed GH secretion in a dose-dependent manner, whereas it caused a significant (P < 0.05) increase in insulin and glucose concentrations without changing glucagon concentrations. From these results, we conclude that the postprandial change in ruminal VFA concentration may be a physiological signal which modifies GH and insulin secretion in sheep.     

Vitamin E concentrations in blood plasma of sheep and in sheep tissues after a single intraruminal or intraperitoneal administration of DL-alpha-tocopheryl acetate

Twenty-five yearling wethers, weighing 40 to 45 kg were used in a trial designed to compare the effect of the route of administration of vitamin E upon plasma and tissue vitamin E status. Five control sheep without vitamin E administration were killed at the beginning of the trial. Of the remaining 20 sheep, 10 were given DL-alpha-tocopheryl acetate intraruminally and 10 by intraperitoneal injection. Of these, 10 wethers were killed three days after dosing (five from each treatment, IR3 and IP3) and the remaining wethers were killed eight days after dosing (IR8 and IP8). Blood samples were taken throughout the trial from sheep on the IR8 and IP8 treatments. Samples of whole adrenal gland, heart, liver, kidney, brachiocephalicus muscle, lung, pancreas and spleen were taken from all sheep at slaughter and were analysed for their vitamin E content. The blood plasma results showed that the most important index of vitamin E bioavailability, the area under the plasma concentration versus time curve, was greater in the intraperitoneally than intraruminally dosed sheep. There was a higher concentration of vitamin E in the tissues from the intraperitoneal group than the intraruminal group three days after the intraperitoneal injections. The results suggest that the greatest responses in vitamin E concentration in plasma and the tissues were recorded in sheep following intraperitoneal rather than intraruminal dosing with DL-alpha-tocopheryl acetate.     

Effect of adrenergic drugs on glucose and plasma glucagon and insulin responses to xylazine in sheep

Xylazine was administered intravenously (0.16 mg/kg) to sheep. This was associated with a transient hyperglucagonaemia, hypoinsulinaemia and hyperglycaemia. The rate of glucose appearance as determined by isotope dilution techniques was increased three to four fold during the first 20 minutes after xylazine administration. Phentolamine prevented the xylazine-induced increase in the rate of appearance of glucose, and in concentrations of glucose and glucagon in plasma. The insulin response was not altered by phentolamine. Propranolol had no effect on the glucose and hormonal responses due to xylazine. The xylazine-induced effects on glucose metabolism and secretion by glucagon and insulin appear to be mediated by the alpha-adrenoceptors.     

Plasma concentration of antidiuretic hormone in response to intraruminal administration of butyrate in suckling calves

Our previous study has revealed that providing dry feeds increased the plasma concentration of antidiuretic hormone (ADH) in suckling calves, leading to altered water balance. To examine whether ketone bodies formed from ruminal fermentation-derived butyrate induced ADH secretion in suckling calves, the effects of intraruminal administration of butyrate on plasma concentration of ADH and ketone bodies, plasma and urine osmolality, and urine volume were examined. Six male Holstein calves aged 4 wk were used. Three levels of butyrate (0 g, 22 g and 44 g) were intraruminally administrated in a 3 × 3 Latin square design, and blood plasma and urine were analyzed. Plasma concentration of ketone bodies was increased by intraruminal administration of butyrate within 15 min in a dose-dependent manner, and the elevation of plasma levels continued until 4 h. Plasma concentration of ADH was also increased by the butyrate treatment, and it was higher in the 44 g butyrate group than in the 22 g butyrate group from 15 min to 2 h. The duration of the elevated plasma concentration of ADH was shorter than that of plasma concentration of ketone bodies. The relationship between plasma concentrations of ADH and those of ketone bodies was statistically significant, although the relationship was weaker. In accordance with the elevation of plasma ADH levels, the butyrate treatment resulted in the decreases in urine volume and increases in urine osmolality. Plasma osmolality was not different among the groups. The present results suggest that ruminal butyrate-derived ketone bodies are at least partly responsible for ADH secretion in suckling calves fed with dry feeds, and that the secreted ADH decreases urine volume through the increase in urine osmolality.     

Effects of intraruminal administration of zinc on gastric acid secretion in sheep.

Intraruminal administration of zinc sulphate at 100 and 200 mg Zn/kg bodyweight resulted in central and peripheral effects in sheep. Feed intake was reduced, pH of the duodenal contents elevated and the secretion of acid from isolated pouches of the abomasum doubled. Suggested explanations include a local inhibitory effect of zinc on abomasal acid secretion elevating duodenal pH and a resultant increased release of gastrin stimulating secretion from the pouches.     

Effect of feeding on plasma secretin concentrations in sheep

Changes in plasma secretin concentration during the 24 hours after feeding were observed in five female sheep fed 1500 g of lucerne pellets and 300 g of orchard grass hay once daily. The pre-feeding concentration of plasma secretin was 50 +/- 9 pg ml-1. The plasma secretin concentration began to increase immediately after the beginning of feeding, reached values approximately double the pre-feeding values six hours after feeding, and remained significantly above the pre-feeding value for more than 10 hours after feeding (P less than 0.01 or less than 0.05).     

Relative bioavailability of rafoxanide following intraruminal and intra-abomasal administration in sheep

The bioavailability of rafoxanide was compared after intraruminal and intra-abomasal administration in healthy adult sheep (n = 6) in a single dose, 2 parallel group study at 7.5 mg/kg. Rafoxanide concentrations in plasma were measured by means of HPLC analysis. Primary pharmacokinetic parameters for bioavailability and disposition of rafoxanide in plasma for both routes of administration were determined by non-compartmental and non-linear, 1-compartmental pharmacokinetic analysis, respectively. Significantly (P < or = 0.05) higher peak plasma concentrations (c(max)) of rafoxanide and a more rapid rate of absorption (c. 3.5 times) was observed in sheep after intra-abomasal (i-a) administration compared to intraruminal (i.r.) administration. A significantly (P < or = 0.05) longer lag period (t(lag)) before absorption (6.8 +/- 2.9 h) occurred after i.r. than after i-a treatment (1.9 +/- 0.6 h). There was no significant difference (P > 0.05) in AUC, MRT and in the rates of elimination (k10-HL and t(1/2beta)) between the i.r. and i-a routes of administration. The results of the study demonstrated the important influence of the rumino-reticulum on absorption of rafoxanide in sheep.     

The effects of dietary nitrate on plasma glucose and insulin sensitivity in sheep

Nitrate (NO₃^¯) is an effective non‐protein nitrogen source for gut microbes and reduces enteric methane (CH₄) production in ruminants. Nitrate is reduced to ammonia by rumen bacteria with nitrite (NO₂^¯) produced as an intermediate. The absorption of NO₂^¯ can cause methaemoglobinaemia in ruminants. Metabolism of NO₃^¯ and NO₂^¯ in blood and animal tissues forms nitric oxide (NO) which has profound physiological effects in ruminants and has been shown to increase glucose uptake and insulin secretion in rodents and humans. We hypothesized that absorption of small quantities of NO₂^¯ resulting from a low‐risk dose of dietary NO₃^¯ will increase insulin sensitivity (S_I) and glucose uptake in sheep. We evaluated the effect of feeding sheep with a diet supplemented with 18 g NO₃^¯/kg DM or urea (Ur) isonitrogenously to NO₃^¯, on insulin and glucose dynamics. A glucose tolerance test using an intravenous bolus of 1 ml/kg LW of 24% (w/v) glucose was conducted in twenty sheep, with 10 sheep receiving 1.8% supplementary NO₃^¯ and 10 receiving supplementary urea isonitrogenously to NO₃^¯. The MINMOD model used plasma glucose and insulin concentrations to estimate basal plasma insulin (I_b) and basal glucose concentration (G_b), insulin sensitivity (S_I), glucose effectiveness (S_G), acute insulin response (AIRg) and disposition index (DI). Nitrate supplementation had no effect on I_b (p > .05). The decrease in blood glucose occurred at the same rate in both dietary treatments (S_G; p = .60), and there was no effect of NO₃^¯ on either G_b, S_I, AIRg or DI. This experiment found that the insulin dynamics assessed using the MINMOD model were not affected by NO₃^¯ administered to fasted sheep at a low dose of 1.8% NO₃^¯ in the diet.     

Pharmacokinetics of ivermectin in sheep following intravenous, intra-abomasal or intraruminal administration

The pharmacokinetics of ivermectin in plasma following intravenous, intra-abomasal, and intraruminal administration to sheep was determined. When given intravenously, ivermectin was very slowly eliminated with a terminal half-life of 178 h and a volume of distribution at steady state of 5.3 l/kg indicating sequestration in a temporary depot. Intra-abomasal administration resulted in rapid absorption, a peak plasma concentration of 60.6 ng/ml at 4.4 h, and 100% bioavailability. However, intraruminal administration produced a much lower peak concentration (17.6 ng/ml at 23.5 h) and bioavailability (25.1%). A subsequent in vitro study indicated that ivermectin may be rapidly metabolized in the rumen.     

Feed aversion induced by intraruminal infusion with larkspur extract in cattle

Twelve Hereford heifers were infused with larkspur extract (group 1, n = 4), lithium chloride solution (group 2, n = 4), or sodium chloride solution (group 3, n = 4). After 3 weeks of being fed basal ration (meadow grass hay), all heifers were offered a ration of alfalfa pellets (3,400 g) in a 2-phase, single-day feeding regimen. In phase 1, the amount eaten within 45 minutes was measured by weigh-back of uneaten pellets. In phase 2, cattle that ate greater than 150 g of pellets in phase 1 were offered the balance of uneaten pellets and were infused with their respective designated solution. Five pairings of pellet feedings and appropriate infusions were given at 2- or 3-day intervals to initially induce feed aversion. Heifers in groups 1 and 2 developed a strong aversion to pellets by the 5th feeding. Persistence of aversion was tested twice at weekly intervals. Infusion of cattle with larkspur extract or lithium chloride solution induced a persistent aversion to an otherwise palatable feed.